MedCrypt, Inc., a San Diego, CO-based proactive cybersecurity solution provider for medical device manufacturers, extended its Series B financing.
The round was led by Dexcom Ventures.
This extension follows MedCrypt’s Series B funding round in November 2022 with investments from Intuitive Ventures, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), bringing the company’s funding to date to $36.4m.
The company intends to use the funds to grow its engineering team to support the growing demand for cybersecurity in devices – across all products – remaining aligned with requirements set by the FDA and the cybersecurity provisions in the latest Consolidated Appropriations Act, 2023.
Led by CEO Mike Kijewski, MedCrypt is helping healthcare technology companies ensure medical devices are secure by design. The company provides cybersecurity products and strategic management consulting to expedite the go-to-market process of medical device manufacturers’ new life-saving connected technologies. MedCrypt currently provides enhanced security products and services for seven of the top 10 medical device manufacturers as well as startups and mid-sized companies, including the leading manufacturers of surgical robotics technologies and virtual reality applications for minimally invasive surgery.
FinSMEs
25/01/2023